Sichuan Biokin Stock Soars 12.46%, Hits Intraday High of CNY 288.93

Sichuan Biokin Pharmaceutical Co., Ltd. has experienced a significant surge in its stock price, gaining 12.46% on March 27, 2026. The stock reached an intraday high of CNY 288.93, showcasing notable activity in the pharmaceuticals and biotechnology sector. In terms of performance metrics, Sichuan Biokin has outperformed the China Shanghai Composite index, which recorded a modest increase of 0.63% on the same day. Over the past week, the company's stock rose by 5.64%, while the index declined by 1.09%. The one-month performance also reflects a positive trend, with a gain of 8.38% compared to the index's drop of 5.99%. Despite these short-term gains, the company has faced challenges, reporting negative results for the last four consecutive quarters. Key financial indicators show a net sales decline of 63.52% and a net profit loss of CNY 500.37 million. The company's market capitalization stands at CNY 29,530 million, positioning it as a large-cap entity within its industry.